Delivery Order SPE2DE21D7020-SPE2D625F2GVG
- Not listed
- Boston Scientific Corp was awarded a delivery order valued at $3,326.30 by the Defense Health Agency's Medical Supply Chain for enroute TCAR stents, with performance in Marlborough, MA. The contract was awarded on August 12, 2025, with an ultimate completion date of August 19, 2025, and utilizes fixed-price pricing with economic price adjustment. This is an open competition award with no set-aside designation, allowing Boston Scientific to compete directly against other qualified vendors in...
- Boston Scientific Corp, a leading global medical technology company headquartered in Marlborough, Massachusetts, was awarded a delivery order valued at $7,593.10 for EnRoute TCAR stents on August 14, 2025. This fixed-price contract with economic price adjustment is scheduled for ultimate completion by August 21, 2025, and will be performed at Boston Scientific's Marlborough facility. The award is being funded through the Defense Health Agency's Medical Supply Chain, a defense-focused federal...
- Boston Scientific Corp, headquartered in Marlborough, Massachusetts, was awarded a fixed-price delivery order valued at $7,593.10 by the Defense Health Agency's Medical Supply Chain on August 20, 2025, with an ultimate completion date of August 27, 2025. The contract involves the supply of enroute TCAR (transcarotid artery revascularization) stents, specialized cardiovascular intervention devices used in minimally invasive procedures. This delivery order was competitively awarded with no...
- The Defense Health Agency's Medical Supply Chain awarded a delivery order valued at $3,326.30 to Boston Scientific Corp for EnRoute TCAR stents on July 25, 2025, with an ultimate completion date of August 1, 2025. This fixed-price contract with economic price adjustment carries no set-aside designation, allowing Boston Scientific to compete openly in the federal marketplace. The work will be performed at Boston Scientific's facility in Marlborough, Massachusetts, where the company manufactures...
- This is a federal contract award to Boston Scientific Corp, a global medical technology company, by the Defense Health Agency (DHA) for the delivery of ENROUTE TCAR stents. The contract is a Delivery Order with a Fixed Price with Economic Price Adjustment pricing type, and a ceiling value of $3,796.55. The contract does not have a set-aside designation. The performance period extends to June 10, 2025. Boston Scientific is also the holder of two federal Indefinite Delivery Vehicles (IDVs) with...
- This federal contract award was issued by the Defense Health Agency (DHA) to Boston Scientific Corp, a global medical technology company headquartered in Marlborough, Massachusetts. The $3,796.55 fixed-price with economic price adjustment delivery order contract is for the provision of ENROUTE TCAR STENTS, which are specialized medical devices used in cardiovascular procedures. The contract has an ultimate completion date of July 16, 2025 and was awarded on July 9, 2025. It is not designated...
- This is a federal contract award to Boston Scientific Corp, a global medical technology company, by the Veterans Integrated Service Network 4 (VISN 4), a division of the U.S. Department of Veterans Affairs (VA). The contract is for the delivery of TCAR stents, a type of cardiovascular medical device, with a ceiling value of $94,179.00. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an ultimate completion date of October 3, 2025. The award was made on August 29,...
- Boston Scientific Corp, a global medical technology company headquartered in Marlborough, Massachusetts, has been awarded a delivery order valued at $3,010.72 for wallstents under the Defense Health Agency's Medical Supply Chain program. The contract, awarded on August 11, 2025, with an ultimate completion date of August 18, 2025, utilizes fixed-price pricing with economic price adjustment. This delivery order represents part of Boston Scientific's broader federal portfolio, which encompasses...
- Boston Scientific Corp has been awarded a delivery order valued at $22,480.61 for wallstents under a Defense Health Agency Medical Supply Chain contract. The award, issued on August 19, 2025, with an ultimate completion date of August 26, 2025, utilizes fixed-price pricing with economic price adjustment terms. The contract carries no set-aside designation, allowing Boston Scientific to compete openly in the federal marketplace. Performance will take place at the company's Marlborough,...
- Boston Scientific Corporation, doing business as Boston Scientific, has been awarded a $16,657.72 fixed price with economic price adjustment delivery order from the Defense Logistics Agency Troop Support Medical for TAVR EMB protection. The delivery order was issued on December 12, 2023 under an indefinite delivery contract vehicle and has a completion date of December 19, 2023. No set aside designation was specified. As a manufacturer of medical devices, Boston Scientific will provide...
- SPE2DE21D7020Indefinite Delivery Contract
- SPE2DE21D7020-SPE2D625F2GVGDelivery Order
Boston Scientific Corp has been awarded a delivery order valued at $11,389.65 for enroute TCAR stents under a Defense Health Agency Medical Supply Chain contract. The award, issued on September 2, 2025, with an ultimate completion date of September 9, 2025, represents a fixed-price contract with economic price adjustment provisions. The work will be performed at Boston Scientific's facility in Marlborough, Massachusetts. No set-aside designation was applied to this award, indicating open competition in the federal marketplace. This delivery order exemplifies Boston Scientific's established role as a critical supplier of specialized cardiovascular medical devices to federal healthcare agencies. The company maintains a substantial portfolio of contracts with the Defense Health Agency and Department of Veterans Affairs, providing advanced medical technologies including stents, catheters, and other interventional cardiology equipment. The enroute TCAR stents support the Defense Health Agency's mission to deliver comprehensive medical care to service members and their beneficiaries, leveraging Boston Scientific's expertise in manufacturing and distributing innovative cardiovascular solutions.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $11.4k | 9/2/25 |